The Coriell Institute for Medical Research, Cooper University Health Care and Cooper Medical School of Rowan University (CMSRU) are launching the Camden Opioid Research Initiative (CORI), a first-of-its-kind undertaking to investigate the genetic and biological factors that contribute to the development of opioid use disorder (also referred to as opioid dependence or addiction). Opioid overdoses continue to climb in New Jersey and nationally and the opioid addiction epidemic is one of the most urgent public health concerns of our time. This year is the deadliest year of this epidemic in the Garden State.
read moreResearchers from the Coriell Institute for Medical Research will present preliminary research findings at the Military Health System Research Symposium (MHSRS) in Kissimmee, Florida this week. The Coriell scientists will disclose and discuss their work through both posters and breakout session presentations.
read moreCoriell Institute for Medical Research today announced the promotion of two of its scientists to new leadership roles. Alissa Resch, PhD, is now the Institute’s Chief Scientific Officer and Nahid Turan, PhD, is now Chief Laboratory Officer. Drs. Resch and Turan previously served as Director of Biobanking Operations and Director of Laboratory Operations, respectively.
read moreCoriell’s system is designed to identify and monitor internal and external factors that impact operations and understand the needs and expectations of all interested parties. The system follows the Plan-Do-Check-Act (PDCA) cycle and monitors the performance of all operations tied to quality and customer satisfaction.
read moreThe Coriell Institute for Medical Research is proud to announce the release of new samples representing N-glycanase deficiency, caused by a mutation on the NGLY 1 gene, also known as Congenital Disorder of Deglycosylation (CDDG). These extraordinarily well characterized samples come from the National Human Genome Research Institute (NHGRI) Undiagnosed Disease Program (UDP) and will be distributed from the National Institute for General Medical Sciences (NIGMS) Human Genetic Cell Repository (HGCR) housed at Coriell.
read moreThe Coriell Institute for Medical Research is deeply saddened to announce the sudden passing of its President and CEO, Michael Christman, PhD.
read moreStefan Zajic, PhD, a principal research scientist at the Coriell Institute for Medical Science, will present at the upcoming American Society for Human Genetics’ annual meeting preliminary findings reporting a new gene variant that correlates to increased risk for stroke. The study also suggests that daily aspirin treatment reduces or eliminates the risk for those with the variant.
read moreThe Coriell Institute for Medical Research is proud to announce the addition of longtime South Jersey community leader and philanthropist George E. Norcross III to its Board of Trustees. Norcross’ legacy as a vocal advocate for the city of Camden and its health care and life sciences industries makes him a perfect fit for Coriell, a leading research nonprofit which was founded in the city nearly 65 years ago and has called it home since.
read moreCoriell’s Stefan Zajic, PhD, a principal research scientist in the Coriell Personalized Medicine Collaboration (CPMC), will present this month at Start Talking Science, an annual event in Philadelphia which allows members of the local scientific community to share their scientific passions with the general public.
read moreThis July, two grandsons of famed South Jersey scientist Lewis Coriell are following in his footsteps, developing a passion for medicine and biology at the very Camden research institute he founded.
read more